Literature DB >> 20969866

Menin stimulates homology-directed DNA repair.

A Gallo1, S Agnese, I Esposito, M Galgani, V E Avvedimento.   

Abstract

Menin, the nuclear protein encoded by the Multiple Endocrine Neoplasia type 1 (MEN1) gene, acts as a tumor suppressor. It interacts with a large number of proteins involved in chromatin modification, transcription, cell cycle checkpoint and DNA repair, though its exact function is not clear. We report that in human cells menin stimulates homology-directed (HD) DNA repair induced by the rare endonuclease I-SceI and it accumulates with Chk1 at the site of the double strand break. In addition, menin and Chk1 interact in vivo. Deletion of the first 228 amino acids of menin impairs the interaction with Chk1 and the ability to stimulate HD repair, suggesting that the complex menin-Chk1 on the damaged chromatin facilitates homologous recombination.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969866     DOI: 10.1016/j.febslet.2010.10.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Trithorax group proteins: switching genes on and keeping them active.

Authors:  Bernd Schuettengruber; Anne-Marie Martinez; Nicola Iovino; Giacomo Cavalli
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

2.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

3.  Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice.

Authors:  Chad Hall; Laurent Ehrlich; Fanyin Meng; Pietro Invernizzi; Francesca Bernuzzi; Terry C Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  J Surg Res       Date:  2017-05-11       Impact factor: 2.192

4.  Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors.

Authors:  Olga Lakiza; Julian Lutze; Alyx Vogle; Jelani Williams; Abde Abukdheir; Paul Miller; Chih-Yi 'Andy' Liao; Sean P Pitroda; Carlos Martinez; Andrea Olivas; Namrata Setia; Stephen J Kron; Ralph R Weichselbaum; Xavier M Keutgen
Journal:  Endocr Relat Cancer       Date:  2022-03-21       Impact factor: 5.900

5.  MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.

Authors:  Minggang Fang; Fen Xia; Meera Mahalingam; Ching-Man Virbasius; Narendra Wajapeyee; Michael R Green
Journal:  Mol Cell Biol       Date:  2013-05-06       Impact factor: 4.272

Review 6.  Ovarian cancer: in search of better marker systems based on DNA repair defects.

Authors:  Dominic Varga; Miriam Deniz; Lukas Schwentner; Lisa Wiesmüller
Journal:  Int J Mol Sci       Date:  2013-01-04       Impact factor: 5.923

7.  Radiological surveillance in multiple endocrine neoplasia type 1: a double-edged sword?

Authors:  Ruth Therese Casey; Deborah Saunders; Benjamin George Challis; Deborah Pitfield; Heok Cheow; Ashley Shaw; Helen Lisa Simpson
Journal:  Endocr Connect       Date:  2017-03-15       Impact factor: 3.335

8.  Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.

Authors:  Jing Ye; Jie Zha; Yuanfei Shi; Yin Li; Delin Yuan; Qinwei Chen; Fusheng Lin; Zhihong Fang; Yong Yu; Yun Dai; Bing Xu
Journal:  Clin Epigenetics       Date:  2019-10-07       Impact factor: 6.551

9.  Genomic footprints of activated telomere maintenance mechanisms in cancer.

Authors:  Lina Sieverling; Chen Hong; Sandra D Koser; Philip Ginsbach; Kortine Kleinheinz; Barbara Hutter; Delia M Braun; Isidro Cortés-Ciriano; Ruibin Xi; Rolf Kabbe; Peter J Park; Roland Eils; Matthias Schlesner; Benedikt Brors; Karsten Rippe; David T W Jones; Lars Feuerbach
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.